SUCCESSOR-2
Phase 3 Study Evaluating the Safety and Effectiveness of Investigational Drug Mezigdomide in Combination with Carfilzomib and Dexamethasone in Relapsed or Refractory Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your home - or near family and friends.
Diagnosis
Treatment History
Prior BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 22 by
OhioHealth Riverside Methodist Hospital
Columbus, OH
- Accepting patients
- Show Principal Investigator
- Not yet accepting
- Show Principal Investigator
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsNorthwest Medical Specialties (Gig Harbor)
Gig Harbor, WA
- Accepting patients
- Show Principal Investigator
Kaiser Permanente Orange County
Irvine Medical Center
Irvine, CA
This trial location is only accepting patients with Kaiser Permanente Insurance.
- Accepting patients
- Show Principal Investigator
Augusta University Medical Center
Augusta, GA
- Not yet accepting
- Show Principal Investigator
Houston Methodist Hospital
Houston, TX
- Accepting patients
- Show Principal Investigator
Baylor Scott & White Hospital
Temple, TX
- Accepting patients
- Show Principal Investigator
Los Angeles Cancer Network (Los Angeles)
Los Angeles, CA
- Accepting patients
Montefiore Medical Center
Bronx, NY
- Accepting patients
- Accepting patients
- Show Principal Investigator
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.